Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiometabolic Effects of Eplerenone in HIV Infection
NCT02629094Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2015
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of eplerenone in Cardiac steatosis (CS), hepatic steatosis, sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 2015; status: terminated.
02
Drugs
eplerenone
03
Conditions
Cardiac steatosis (CS)hepatic steatosis
Beyond the preview
Go deeper on NCT02629094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02629094.